SU-13,437

Known as: SU 13,437, SU13,437 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-2006
0119712006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
pidemic drug clofibrate (ethyl-a-p-chlorophenoxyisobutyr ate) in lowering serum lipid levels in experimental animals (49) but it… (More)
  • figure 7
  • table 4
  • table 4
Is this relevant?
1979
1979
pidemic drug clofibrate (ethyl-a-p-chlorophenoxyisobutyr ate) in lowering serum lipid levels in experimental animals (49) but it… (More)
  • figure 7
  • table 4
  • table 4
Is this relevant?
1977
1977
Nafenopin (2-methyl-2-[P-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy] propionic acid; Su-13,437), a potent hypolipidemic hepatic… (More)
Is this relevant?
1975
1975
Administration of nafenopin (SU-13-437) to male rats for two days leads to a doubling of bile production and a 50% increase in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1971
1971
The oral administration of 25 mg 2-methyl-2-[p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy] propionic acid (SU-13,437) per kilogram… (More)
  • table II
Is this relevant?